{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:03:40Z","timestamp":1780297420363,"version":"3.54.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.trim.2026.102393","type":"journal-article","created":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T15:19:01Z","timestamp":1777735141000},"page":"102393","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond biopsy and drug levels: Are TTV and dd-CFDNA the next frontiers in transplant monitoring?"],"prefix":"10.1016","volume":"96","author":[{"given":"Priya","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Ahlawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2026.102393_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00705-015-2363-9","article-title":"Human anelloviruses: an update of molecular, epidemiological and clinical aspects","volume":"160","author":"Spandole","year":"2015","journal-title":"Arch. Virol."},{"issue":"1","key":"10.1016\/j.trim.2026.102393_bb0010","article-title":"Torque Teno virus loads after lung transplantation","volume":"8","author":"Maggi","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.trim.2026.102393_bb0015","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/infdis\/jiy306","article-title":"Torque Teno virus viremia as a biomarker for infectious disease risk in kidney allograft recipients","volume":"218","author":"Strassl","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.trim.2026.102393_bb0020","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.cell.2013.10.034","article-title":"Temporal response of the human virome to immunosuppression","volume":"155","author":"De Vlaminck","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.trim.2026.102393_bb0025","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/infdis\/jiae626","article-title":"Anelloviruses and cancer","volume":"231","author":"Tang","year":"2024","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.trim.2026.102393_bb0030","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/infdis\/jit423","article-title":"Torque Teno virus in children who underwent orthotopic liver transplantation: new insights about a common pathogen","volume":"209","author":"B\u00e9land","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.trim.2026.102393_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1168400","article-title":"Understanding Torquetenovirus (TTV) as an immune marker","volume":"10","author":"Gore","year":"2023","journal-title":"Front. Med."},{"issue":"12","key":"10.1016\/j.trim.2026.102393_bb0040","first-page":"1532","article-title":"Torque Teno virus as a biomarker to monitor infection and rejection in solid organ transplantation: systematic review and meta-analysis","volume":"26","author":"Fern\u00e1ndez-Ruiz","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"issue":"241","key":"10.1016\/j.trim.2026.102393_bb0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection","volume":"6","author":"Vlaminck","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"7","key":"10.1016\/j.trim.2026.102393_bb0050","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts","volume":"28","author":"Bloom","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"4","key":"10.1016\/j.trim.2026.102393_bb0055","first-page":"356","article-title":"Donor-derived cell-free DNA in heart transplantation: a prospective multicenter study","volume":"41","author":"Khush","year":"2022","journal-title":"J. Heart Lung Transplant."},{"issue":"3","key":"10.1016\/j.trim.2026.102393_bb0060","first-page":"703","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from donor-derived cell-free DNA","volume":"18","author":"Agbor-Enoh","year":"2018","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102393_bb0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR","volume":"8","author":"Sigdel","year":"2019","journal-title":"J. Clin. Med."},{"issue":"1","key":"10.1016\/j.trim.2026.102393_bb0070","first-page":"98","article-title":"Donor-derived cell-free DNA monitoring in lung transplantation","volume":"204","author":"Khush","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"6","key":"10.1016\/j.trim.2026.102393_bb0075","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients","volume":"18","author":"Grskovic","year":"2016","journal-title":"J. Mol. Diagn."},{"issue":"6","key":"10.1016\/j.trim.2026.102393_bb0080","first-page":"1336","article-title":"Diagnostic application of donor-derived cell-free DNA in kidney transplantation: a prospective study","volume":"95","author":"Whitlam","year":"2019","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.trim.2026.102393_bb0085","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/ajt.13387","article-title":"Cell-free DNA: an upcoming biomarker in transplantation","volume":"15","author":"Gielis","year":"2015","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.trim.2026.102393_bb0090","first-page":"1167","article-title":"High donor-derived cell-free DNA levels identify patients with severe graft injury after kidney transplantation","volume":"98","author":"Stites","year":"2020","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.trim.2026.102393_bb0095","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.healun.2021.12.009","article-title":"Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care","volume":"41","author":"Keller","year":"2022","journal-title":"J. Heart Lung Transplant"},{"key":"10.1016\/j.trim.2026.102393_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000001063","article-title":"Plasma donor-derived cell-free DNA levels are increased during acute cellular rejection after lung transplant: pilot data","volume":"6","author":"Sayah","year":"2020","journal-title":"Transplant. Direct"},{"issue":"8","key":"10.1016\/j.trim.2026.102393_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study","volume":"40","author":"Jang","year":"2021","journal-title":"J. Heart Lung Transplant."},{"issue":"4","key":"10.1016\/j.trim.2026.102393_bb0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/jalm\/jfab171","article-title":"Biological variation of donor-derived cell-free DNA in stable lung transplant recipients","volume":"7","author":"Keller","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"10.1016\/j.trim.2026.102393_bb0115","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.trim.2026.102393_bb0120","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1111\/ajt.15810","article-title":"Torque Teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-a prospective observational trial","volume":"20","author":"Doberer","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.trim.2026.102393_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00467-020-04606-3","article-title":"Torque Teno viral load reflects immunosuppression in paediatric kidney-transplanted patients-a pilot study","volume":"36","author":"Uhl","year":"2021","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.trim.2026.102393_bb0130","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1743-422X-6-134","article-title":"Torque Teno virus (TTV) distribution in healthy Russian population","volume":"6","author":"Vasilyev","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.trim.2026.102393_bb0135","article-title":"Early post-transplant recipient tissue injury predicts allograft function, rejection, and survival in lung transplant recipients, evidence from cell-free DNA","author":"Alnababteh","year":"2025","journal-title":"Eur. Respir. J."},{"issue":"9","key":"10.1016\/j.trim.2026.102393_bb0140","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/j.ajt.2025.04.011","article-title":"Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation","volume":"25","author":"Charya","year":"2025","journal-title":"Am. J. Transplant."}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327426000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:49:35Z","timestamp":1780296575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327426000511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S0966327426000511"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2026.102393","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond biopsy and drug levels: Are TTV and dd-CFDNA the next frontiers in transplant monitoring?","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2026.102393","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102393"}}